Immunex Message Board - Msg: 2827403

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Swift who wrote (159)	11/26/1997 11:43:00 PM
From: targetedmoab	of 656

Bob, As I understand it, Cnto drug will not be indicated, at least at first for RA. I cant remember what they are going for. Even if it is nearly effective as Immunexs, I understand the side effect profile is pretty high and antibodies have been formed against it in a number of patients. Enbrels side effect profile is low with few site reactions and maybe 1 added cold per year. I think only 1 patient so far has produced antibodies to it. All in All it is a cleaner drug profile. In RA, Enbrel,the cleaner drug will win since patients will be taking it long term. Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next